RI-MUHC success in grant competition for transplantation research
Researchers awarded funds from the Canadian Donation and Transplantation Research Program for innovative research projects in organ and tissue transplantationSource: CDTRP and RI-MUHC. Announced on July 13, the Canadian Donation and Transplantation Research Program (CDTRP) will fund three new projects led by organ and tissue transplant researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) and the MUHC.(L-R) CDTRP grant recipients from the Research Institute of the MUHC: Steven Paraskevas, Amine Benmassaoud and Tania Janaudis-FerreiraSince 2012 the CDTRP has supported research and innovation that addresses barriers within the fields of donation and transplantation, with the ultimate goal of advancing long-term health outcomes and quality of life for Canadian transplant patients. The CDTRP Research Innovation Grant competition supports new peer-reviewed pilot research projects that align with CDTRP’s One-Transplant-for-Life vision, which is to fulfill every donor opportunity and turn transplant into a cure. This year’s results were exceptional for the RI-MUHC, as three of the four grants issued in the Research Innovation category were awarded to proposals from our research community.Congratulations to the awardees!Steven Paraskevas, MD, PhD, scientist in the Metabolic Disorders and Complications Program and Corinne A Hoesli, MD, for the project “Making every pancreatic islet count – engineering a vascularized transplantation system to treat type 1 diabetes”Amine Benmassaoud, MD, associate investigator in the Cardiovascular Health Across the Lifespan Program, for the project “Does a 4-week prehabilitation program improve frailty in patients with cirrhosis undergoing liver transplantation? A feasibility trial”Tania Janaudis-Ferreira, PhD, junior scientist in the Translational Research in Respiratory Diseases Program and trainee Nicholas Bourgeois for the project “Virtual home-based pre-habilitation program in lung transplant candidates”July 22, 2021
RI-MUHC team identifies potential diagnostic biomarker for pancreatic cancer
Study demonstrates that regenerative protein 3A/3B promotes a newly recognized precursor of pancreatic...
RI-MUHC trainee wins award at Canadian Society of Nephrology meeting
Congratulations to Tho-Alfakar Al-Aubodah!
How does the hunger-suppressing hormone leptin cross the blood-brain barrier?
Specialized cells called pericytes play a key role, reveals new work from researchers at the RI-MUHC
New research looks at vaccination efficacy and hemodialysis
Dialysis patients do not develop adequate antibodies with one dose of SARS-CoV-2 vaccine
FALL 2020 CIHR COMPETITION RESULTS
RI-MUHC teams received $6.9 million in project funding and $2 million more for COVID-19 research
Understanding the health impact of inactivity for the benefit of older adults and astronauts
A study using bedrest as an analog to microgravity will provide data for eight Canadian research projects
INESSS honours McGill team for contributions to pandemic hospital projections
Public health researchers David Buckeridge and Mathieu Maheu-Giroux lead valuable support initiative
Suzanne Morin named to CIHR Institute Advisory Board
RI-MUHC researcher promotes musculoskeletal health for Canadians
Driving Personalized Medicine: The 2020 RI-MUHC Annual Report is online!
An invitation from Dr. Miguel Burnier Jr.